Inhalation Sciences Sweden AB (publ)

NGM:ISAB Stock Report

Market Cap: SEK 65.8m

Inhalation Sciences Sweden Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Manoush Masarrat

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.6yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure3.9yrs

Recent management updates

Recent updates

We're Not Counting On Inhalation Sciences Sweden (NGM:ISAB) To Sustain Its Statutory Profitability

Dec 29
We're Not Counting On Inhalation Sciences Sweden (NGM:ISAB) To Sustain Its Statutory Profitability

CEO

Manoush Masarrat (46 yo)

4.6yrs

Tenure

Mr. Manoush Masarrat has been Chief Executive Officer at Inhalation Sciences Sweden AB (publ) since September 16 2019. Mr. Masarrat had served as Director of Inhalation Sciences Sweden AB (publ) since Dece...

Board Members

NamePositionTenureCompensationOwnership
Per Gerde
Chief Scientific Officer & Directorno datano data5.08%
SEK 3.3m
Per Wollmer
Member of Advisory Boardno datano datano data
Daniel Spasic
Chairman of the Board3.9yrsno datano data
Jan Hellqvist
Director1.6yrsno datano data
Sonja Gerde
Director5.9yrsno datano data
Gary Pitcairn
Member of Advisory Boardno datano datano data
Martin Wehling
Member of Advisory Boardno datano datano data
Magnus Svartengren
Member of Advisory Boardno datano datano data
Carsten Ehrhardt
Member of Advisory Boardno datano datano data

3.9yrs

Average Tenure

58yo

Average Age

Experienced Board: ISAB's board of directors are considered experienced (3.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/04/29 19:47
End of Day Share Price 2024/01/31 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Inhalation Sciences Sweden AB (publ) is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gustaf MeyerRedeye